Acepromazine, polymyxin B, fentanyl... the list of essential substances for the treatment of horses and other equines was published in the EU Official Journal on 19 May. A six-month withdrawal period applies to all these products. Consequently, FVE has updated its ‘cascade’ guide, a visual tool offering a flowchart-based approach to follow the so-called cascade principle as outlined in the EU Veterinary Medicines Regulation (2019/6, articles 112-114).
Compliant with the latest EU regulations
The list of essential treatments for horses is now compliant up to May 2027. ‘After this, it is possible that some products, such as buprenorphine, sevoflurane and fluoresceine, will be removed from the list, warns Nancy de Briyne, FVE executive director.
The guide also recalls the prescribers’ responsibilities regarding record-keeping, and if prior antimicrobial sensitivity testing is required.
Updated: the FVE cascade guide
The FVE leaflet provides veterinary prescribers with decision trees to help choose treatment, whether for companion animals, food-producing animals or horses. The cascade is of particular interest if a certain medicine is not available, and is especially beneficial in smaller markets and for minor species. The tool helps vets uphold animal health and welfare, ensuring safe and effective care while safeguarding public health.
(Photo ©Kelly Forrister/Unsplash)